{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:39:50Z","timestamp":1786981190687,"version":"build-2736575974"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2021,10,20]],"date-time":"2021-10-20T00:00:00Z","timestamp":1634688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,10,20]],"date-time":"2021-10-20T00:00:00Z","timestamp":1634688000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Universit\u00e0 degli Studi di Roma La Sapienza"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Ophthalmol"],"published-print":{"date-parts":[[2022,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To describe the ophthalmological characteristics in a Juvenile idiopathic arthritis (JIA) cohort and to evaluate how therapeutic advances have changed the course of the uveitis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Analysis of a retrospective cohort study of consecutive JIA pediatric patients including JIA-associated uveitis (JIA-U) and comparison with a previous study in the same uveitis center assessed before the wide-spread of biological therapy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The total of 49 JIA patients were analyzed, of whom 18 JIA-U, compared with a JIA-U past cohort of 66 patients. Systemic corticosteroids were used significantly less in the current JIA-U group (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.008) than in the past one. JIA-U present cohort was on therapy more frequently with conventional synthetic disease-modifying anti-rheumatic drugs (csDMARDs) than the past group (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.039), mostly treated with methotrexate (93.3%). Furthermore, a larger use of biologic disease-modifying anti-rheumatic drugs (bDMARDs) was described in the current JIA-U group (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.005) also associated with csDMARDs (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.003). Adalimumab was used more (72.7%) in the present JIA-U cohort compared to a larger treatment with infliximab (61.5%) in the past (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.005). Higher number of uveitis recurrences was observed in the previous cohort compared to the current one (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.005). Fewer complications were described in this study than in the previous: posterior synechiae (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.007), cataract (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001), band keratopathy (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001), and elevated intraocular pressure (IOP) (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.047).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Current therapies reduced the uveitis recurrences and ocular complications including cataract due also to the lower use of corticosteroids. The new close collaboration with the pediatric rheumatologic center in the same University has contributed to the care improvement and decrease of uveitis complications.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s10792-021-02043-1","type":"journal-article","created":{"date-parts":[[2021,10,20]],"date-time":"2021-10-20T16:31:21Z","timestamp":1634747481000},"page":"775-784","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Juvenile idiopathic arthritis-associated\u00a0uveitis in the era of biological therapy: how the disease changed in more than 20\u00a0years of observation in a tertiary referral center in Rome (Italy)"],"prefix":"10.1007","volume":"42","author":[{"given":"E.","family":"Del Giudice","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Simio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Scala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Di Coste","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"La Torre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Spadea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Lubrano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Duse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. P.","family":"Paroli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,10,20]]},"reference":[{"issue":"9783","key":"2043_CR1","doi-asserted-by":"publisher","first-page":"2138","DOI":"10.1016\/s0140-6736(11)60244-4","volume":"377","author":"B Prakken","year":"2011","unstructured":"Prakken B, Albani S, Martini A (2011) Juvenile idiopathic arthritis. Lancet 377(9783):2138\u20132149. https:\/\/doi.org\/10.1016\/s0140-6736(11)60244-4","journal-title":"Lancet"},{"issue":"1","key":"2043_CR2","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s12969-016-0088-2","volume":"14","author":"SLN Clarke","year":"2016","unstructured":"Clarke SLN, Sen ES, Ramanan AV (2016) Juvenile idiopathic arthritis-associated uveitis. Pediatr Rheumatol Online J 14(1):27. https:\/\/doi.org\/10.1186\/s12969-016-0088-2","journal-title":"Pediatr Rheumatol Online J"},{"key":"2043_CR3","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1007\/978-3-319-59963-2_13","volume":"5","author":"E Del Giudice","year":"2017","unstructured":"Del Giudice E, Swart JF, Wulffraat NM (2017) Juvenile idiopathic arthritis. Comorbidity Rheum Dis 5:265\u2013288","journal-title":"Comorbidity Rheum Dis"},{"issue":"1","key":"2043_CR4","doi-asserted-by":"publisher","first-page":"81","DOI":"10.3109\/09273948.2015.1077976","volume":"24","author":"RM Amin","year":"2016","unstructured":"Amin RM, Miserocchi E, Thorne JE et al (2016) Treatment options for juvenile idiopathic arthritis (JIA) associated uveitis. Ocul Immunol Inflamm 24(1):81\u201390. https:\/\/doi.org\/10.3109\/09273948.2015.1077976","journal-title":"Ocul Immunol Inflamm"},{"issue":"8","key":"2043_CR5","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1136\/annrheumdis-2018-213131","volume":"77","author":"T Constantin","year":"2018","unstructured":"Constantin T, Foeldvari I, Anton J et al (2018) Consensus-based recommendations for the management of uveitis associated with juvenile idiopathic arthritis: the SHARE initiative. Ann Rheum Dis 77(8):1107\u20131117. https:\/\/doi.org\/10.1136\/annrheumdis-2018-213131","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"2043_CR6","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1080\/09273940590951061","volume":"13","author":"EN Yu","year":"2005","unstructured":"Yu EN, Meniconi ME, Tufail F et al (2005) Outcomes of treatment with immunomodulatory therapy in patients with corticosteroid-resistant juvenile idiopathic arthritis-associated chronic iridocyclitis. Ocul Immunol Inflamm 13(5):353\u2013360. https:\/\/doi.org\/10.1080\/09273940590951061","journal-title":"Ocul Immunol Inflamm"},{"issue":"2","key":"2043_CR7","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.ajo.2010.08.021","volume":"151","author":"VK Ayuso","year":"2011","unstructured":"Ayuso VK, Van De Winkel EL et al (2011) Relapse rate of uveitis post-methotrexate treatment in juvenile idiopathic arthritis. Am J Ophthalmol 151(2):217\u2013222. https:\/\/doi.org\/10.1016\/j.ajo.2010.08.021","journal-title":"Am J Ophthalmol"},{"issue":"2","key":"2043_CR8","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1177\/112067210701700509","volume":"17","author":"A Heiligenhaus","year":"2007","unstructured":"Heiligenhaus A, Mingels A, Heinz C et al (2007) Methotrexate for uveitis associated with juvenile idiopathic arthritis: value and requirement for additional anti-inflammatory medication. Am J Ophthalmol 17(2):743\u2013748. https:\/\/doi.org\/10.1177\/112067210701700509","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"2043_CR9","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1002\/art.20904","volume":"53","author":"JA Smith","year":"2005","unstructured":"Smith JA, Thompson DJS, Whitcup SM et al (2005) A randomized, placebo-controlled, double-masked clinical trial of etanercept for the treatment of uveitis associated with juvenile idiopathic arthritis. Arthritis Rheum 53(1):18\u201323. https:\/\/doi.org\/10.1002\/art.20904","journal-title":"Arthritis Rheum"},{"issue":"4","key":"2043_CR10","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1136\/ard.2006.058248","volume":"66","author":"P Tynjala","year":"2006","unstructured":"Tynjala P, Lindahl P, Honkanen V et al (2006) Infliximab and etanercept in the treatment of chronic uveitis associated with refractory juvenile idiopathic arthritis. Ann Rheum Dis 66(4):548\u2013550. https:\/\/doi.org\/10.1136\/ard.2006.058248","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"2043_CR11","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1002\/acr.23871","volume":"71","author":"ST Angeles-Han","year":"2019","unstructured":"Angeles-Han ST, Ringold S, Beukelman T et al (2019) 2019 American college of rheumatology\/arthritis foundation guideline for the screening, monitoring, and treatment of juvenile idiopathic arthritis-associated uveitis. Arthritis Care Res (Hoboken) 71(6):703\u2013716. https:\/\/doi.org\/10.1002\/acr.23871","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"17","key":"2043_CR12","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1056\/nejmoa1614160","volume":"376","author":"A Ramanan","year":"2017","unstructured":"Ramanan A, Dick AD, Jones AP et al (2017) Adalimumab plus methotrexate for uveitis in juvenile idiopathic arthritis. N Engl J Med 376(17):1637\u20131646. https:\/\/doi.org\/10.1056\/nejmoa1614160","journal-title":"N Engl J Med"},{"issue":"2","key":"2043_CR13","first-page":"390","volume":"31","author":"RE Petty","year":"2004","unstructured":"Petty RE, Southwood TR, Manners P et al (2004) International league of associations for rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol 31(2):390\u2013392","journal-title":"J Rheumatol"},{"issue":"9563","key":"2043_CR14","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1016\/s0140-6736(07)60363-8","volume":"369","author":"A Ravelli","year":"2007","unstructured":"Ravelli A, Martini A (2007) Juvenile idiopathic arthritis. Lancet 369(9563):767\u2013778. https:\/\/doi.org\/10.1016\/s0140-6736(07)60363-8","journal-title":"Lancet"},{"issue":"1","key":"2043_CR15","doi-asserted-by":"publisher","first-page":"74","DOI":"10.3109\/09273948.2013.855798","volume":"23","author":"MP Paroli","year":"2015","unstructured":"Paroli MP, Abbouda A, Restivo L et al (2015) Juvenile idiopathic arthritis-associated uveitis at an Italian tertiary referral center: clinical features and complications. Ocul Immunol Inflamm 23(1):74\u201381. https:\/\/doi.org\/10.3109\/09273948.2013.855798","journal-title":"Ocul Immunol Inflamm"},{"issue":"3","key":"2043_CR16","doi-asserted-by":"publisher","first-page":"509e16","DOI":"10.1016\/j.ajo.2005.03.057","volume":"140","author":"DA Jabs","year":"2005","unstructured":"Jabs DA, Nussenblatt RB, Rosenbaum JT (2005) Standardization of uveitis nomenclature (SUN) working group. Standardization of uveitis nomenclature for reporting clinical data. Results of the first international workshop. Am J Ophthalmol 140(3):509e16. https:\/\/doi.org\/10.1016\/j.ajo.2005.03.057","journal-title":"Am J Ophthalmol"},{"key":"2043_CR17","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.1542\/peds.2006-0421","volume":"117","author":"J Cassidy","year":"2006","unstructured":"Cassidy J, Kivlin J, Lindsley C, Nocton J (2006) Ophthalmologic examinations in children with juvenile rheumatoid arthritis. Pediatrics 117:1843\u20131845. https:\/\/doi.org\/10.1542\/peds.2006-0421","journal-title":"Pediatrics"},{"issue":"6","key":"2043_CR18","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1093\/rheumatology\/kem053","volume":"46","author":"A Heiligenhaus","year":"2007","unstructured":"Heiligenhaus A, Niewerth M, Ganser G et al (2007) German uveitis in childhood study group. Prevalence and complications of uveitis in juvenile idiopathic arthritis in a population-based nation-wide study in Germany: suggested modification of the current screening guidelines. Rheumatology 46(6):1015\u20131019. https:\/\/doi.org\/10.1093\/rheumatology\/kem053","journal-title":"Rheumatology"},{"issue":"1","key":"2043_CR19","doi-asserted-by":"publisher","first-page":"1e2","DOI":"10.1080\/09273940801899822","volume":"16","author":"J Deschenes","year":"2008","unstructured":"Deschenes J, Murray PI, Rao NA, Nussenblatt RB (2008) International uveitis study group (IUSG): clinical classification of uveitis. Ocul Immunol Inflamm 16(1):1e2. https:\/\/doi.org\/10.1080\/09273940801899822","journal-title":"Ocul Immunol Inflamm"},{"issue":"1","key":"2043_CR20","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.ophtha.2012.07.052","volume":"120","author":"AC Gregory 2nd","year":"2013","unstructured":"Gregory AC 2nd, Kempen JH, Daniel E et al (2013) Systemic immunosuppressive therapy for eye diseases cohort study research group. Ophtalmology 120(1):186\u2013192. https:\/\/doi.org\/10.1016\/j.ophtha.2012.07.052","journal-title":"Ophtalmology"},{"issue":"1","key":"2043_CR21","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s12969-019-0345-2","volume":"17","author":"I Foeldvari","year":"2019","unstructured":"Foeldvari I, Klotsche J, Simonini G et al (2019) Proposal for a definition for response to treatment, inactive disease and damage for JIA associated uveitis based on the validation of a uveitis related JIA outcome measures from the Multinational Interdisciplinary Working Group for uveitis in childhood (MIWGUC). Pediatric Rheumatol Online 17(1):66. https:\/\/doi.org\/10.1186\/s12969-019-0345-2","journal-title":"Pediatric Rheumatol Online"},{"issue":"5","key":"2043_CR22","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1016\/j.ajo.2007.01.033","volume":"143","author":"JE Thorne","year":"2007","unstructured":"Thorne JE, Woreta F, Kedhar SR et al (2007) Juvenile idiopathic arthritis associated uveitis: incidence of ocular complications and visual acuity loss. Am J Opthalmol 143(5):840\u2013846. https:\/\/doi.org\/10.1016\/j.ajo.2007.01.033","journal-title":"Am J Opthalmol"},{"key":"2043_CR23","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/461078","author":"A Moradi","year":"2014","unstructured":"Moradi A, Amin RM, Thorne JE (2014) The role of gender in juvenile idiopathic arthritis- associated uveitis. J Ophthalmol. https:\/\/doi.org\/10.1155\/2014\/461078","journal-title":"J Ophthalmol"},{"key":"2043_CR24","doi-asserted-by":"publisher","DOI":"10.1097\/rhu.0000000000001104","author":"G Conti","year":"2019","unstructured":"Conti G, Chirico V, Porcaro F et al (2019) Frequency and identification of risk factors of uveitis in juvenile idiopathic arthritis: a long-term follow-up study in a cohort of Italian children. J Clin Rheumatol. https:\/\/doi.org\/10.1097\/rhu.0000000000001104","journal-title":"J Clin Rheumatol"},{"issue":"3","key":"2043_CR25","doi-asserted-by":"publisher","first-page":"180","DOI":"10.3109\/09273948.2013.791701","volume":"21","author":"A Heiligenhaus","year":"2013","unstructured":"Heiligenhaus A, Heinz C, Edelsten C et al (2013) (2013) Review for disease of the year: epidemiology of juvenile idiopathic arthritis and its associated uveitis: the probable risk factors. Ocul Immunol Inflamm 21(3):180\u2013191. https:\/\/doi.org\/10.3109\/09273948.2013.791701","journal-title":"Ocul Immunol Inflamm"},{"issue":"7","key":"2043_CR26","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.3899\/jrheum.131494","volume":"41","author":"S Calandra","year":"2014","unstructured":"Calandra S, Gallo MC, Consolaro A et al (2014) Female sex and oligoarthritis category are not risk factors for uveitis in Italian children with juvenile idiopathic arthritis. J Rheumatol 41(7):1416\u20131425. https:\/\/doi.org\/10.3899\/jrheum.131494","journal-title":"J Rheumatol"},{"issue":"6","key":"2043_CR27","doi-asserted-by":"publisher","first-page":"1824","DOI":"10.1002\/art.27416","volume":"62","author":"RK Saurenmann","year":"2010","unstructured":"Saurenmann RK, Levin AV, Feldman BM et al (2010) Risk factors for development of uveitis differ between girls and boys with juvenile idiopathic arthritis. Rheum 62(6):1824\u20131828. https:\/\/doi.org\/10.1002\/art.27416","journal-title":"Rheum"},{"issue":"12","key":"2043_CR28","doi-asserted-by":"publisher","first-page":"2088","DOI":"10.3899\/jrheum.130302","volume":"40","author":"ST Angeles-Han","year":"2013","unstructured":"Angeles-Han ST, Pelajo CF, Vogler LB et al (2013) Risk markers of juvenile idiopathic arthritis-associated uveitis in the childhood arthritis and rheumatology research alliance (CARRA) registry. J Rheumatol 40(12):2088\u20132096. https:\/\/doi.org\/10.3899\/jrheum.130302","journal-title":"J Rheumatol"},{"issue":"7","key":"2043_CR29","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1111\/aos.13388","volume":"95","author":"M Papadopoulou","year":"2017","unstructured":"Papadopoulou M, Zetterberg M, Oskarsdottir S et al (2017) Assessment of the outcome of ophthalmological screening for uveitis in a cohort of Swedish children with juvenile idiopathic arthritis. Acta Ophthalmol 95(7):741\u2013747. https:\/\/doi.org\/10.1111\/aos.13388","journal-title":"Acta Ophthalmol"},{"key":"2043_CR30","doi-asserted-by":"publisher","first-page":"2081","DOI":"10.2147\/opth.s202486","volume":"13","author":"R Taha","year":"2019","unstructured":"Taha R, Papadopoulou M, Zetterberg M et al (2019) Visual function and quality of life in a cohort of swedish children with juvenile idiopathic arthritis. Clin Ophthalmol 13:2081\u20132091. https:\/\/doi.org\/10.2147\/opth.s202486","journal-title":"Clin Ophthalmol"},{"issue":"8","key":"2043_CR31","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.3899\/jrheum.171006","volume":"45","author":"V Cecchin","year":"2018","unstructured":"Cecchin V, Zannin ME, Ferrari D et al (2018) Longterm safety and efficacy of adalimumab and infliximab for uveitis associated with juvenile idiopathic arthritis. J Rheumatol 45(8):1167\u20131172. https:\/\/doi.org\/10.3899\/jrheum.171006","journal-title":"J Rheumatol"},{"issue":"2","key":"2043_CR32","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1007\/s10792-019-01184-8","volume":"40","author":"I Castagna","year":"2019","unstructured":"Castagna I, Roszkowska AM, Alessandrello F et al (2019) Juvenile idiopathic arthritis-associated uveitis: a retrospective analysis from a centre of South Italy. Int. Opthalmol. 40(2):335\u2013342. https:\/\/doi.org\/10.1007\/s10792-019-01184-8","journal-title":"Int. Opthalmol."},{"issue":"6","key":"2043_CR33","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1136\/bjophthalmol-2011-301023","volume":"96","author":"M Hoeve","year":"2012","unstructured":"Hoeve M, Kalinina Ayuso V, Schalij-Delfos NE et al (2012) The clinical course of juvenile idiopathic arthritis-associated uveitis in childhood and puberty. Br J Ophthalmol 96(6):852\u2013856. https:\/\/doi.org\/10.1136\/bjophthalmol-2011-301023","journal-title":"Br J Ophthalmol"},{"issue":"1","key":"2043_CR34","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s12969-019-0333-6","volume":"17","author":"T Hiyama","year":"2019","unstructured":"Hiyama T, Harada Y, Doi T, Kiuchi Y (2019) Early administration of adalimumab for paediatric uveitis due to Beh\u00e7et\u2019s disease. Pediatr Rheumatol Online J 17(1):29. https:\/\/doi.org\/10.1186\/s12969-019-0333-6","journal-title":"Pediatr Rheumatol Online J"},{"key":"2043_CR35","first-page":"458","volume":"31","author":"P Neri","year":"2013","unstructured":"Neri P, Eandi C, Arapi I et al (2013) Long-term control of non-infectious paediatric panuveitis refractory to traditional immunesuppressive therapy successfully treated with Adalimumab (HumiraTM). Clin Exp Rheumatol 31:458\u2013462","journal-title":"Clin Exp Rheumatol"},{"issue":"4","key":"2043_CR36","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1007\/s40272-015-0128-2","volume":"17","author":"MA Lerman","year":"2015","unstructured":"Lerman MA, Rabinovich CE (2015) The future is now: biologics for non-infectious pediatric anterior uveitis. Pediatr Drugs 17(4):283\u2013301. https:\/\/doi.org\/10.1007\/s40272-015-0128-2","journal-title":"Pediatr Drugs"},{"key":"2043_CR37","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1007\/s00417-018-3928-6","volume":"256","author":"I Deitch","year":"2018","unstructured":"Deitch I, Amer R, Tomkins-Netzer O et al (2018) The effect of anti-tumor necrosis factor alpha agents on the outcome in pediatric uveitis of diverse etiologies. Graefes Arch Clin Exp Ophthalmol 256:801\u2013808. https:\/\/doi.org\/10.1007\/s00417-018-3928-6","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"3","key":"2043_CR38","doi-asserted-by":"publisher","first-page":"151.e1","DOI":"10.1016\/j.jaapos.2019.02.006","volume":"23","author":"N Ashkenazy","year":"2019","unstructured":"Ashkenazy N, Saboo US, Abraham A et al (2019) Successful treatment with infliximab after adalimumab failure in pediatric noninfectious uveitis. J AAPOS 23(3):151.e1-151.e5. https:\/\/doi.org\/10.1016\/j.jaapos.2019.02.006","journal-title":"J AAPOS"}],"container-title":["International Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-021-02043-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10792-021-02043-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-021-02043-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,11]],"date-time":"2022-03-11T11:49:22Z","timestamp":1646999362000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10792-021-02043-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,20]]},"references-count":38,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["2043"],"URL":"https:\/\/doi.org\/10.1007\/s10792-021-02043-1","relation":{},"ISSN":["0165-5701","1573-2630"],"issn-type":[{"value":"0165-5701","type":"print"},{"value":"1573-2630","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,20]]},"assertion":[{"value":"29 March 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 October 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}